Free Trial

Doximity (DOCS) Stock Price, News & Analysis

Doximity logo
$17.79 -5.60 (-23.96%)
As of 01:26 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Doximity Stock (NYSE:DOCS)

Advanced

Key Stats

Today's Range
$17.15
$18.40
50-Day Range
$21.11
$27.01
52-Week Range
$17.15
$76.51
Volume
15.20 million shs
Average Volume
3.58 million shs
Market Capitalization
$3.29 billion
P/E Ratio
14.81
Dividend Yield
N/A
Price Target
$31.71
Consensus Rating
Moderate Buy

Company Overview

Doximity Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

DOCS MarketRank™: 

Doximity scored higher than 63% of companies evaluated by MarketBeat, and ranked 26th out of 53 stocks in the services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Doximity has received a consensus rating of Moderate Buy. The company's average rating score is 2.52, and is based on 2 strong buy ratings, 8 buy ratings, 13 hold ratings, and no sell ratings.

  • Upside Potential

    Doximity has a consensus price target of $31.71, representing about 77.3% upside from its current price of $17.88.

  • Amount of Analyst Coverage

    Doximity has been the subject of 18 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Doximity's stock forecast and price target.
  • Earnings Growth

    Earnings for Doximity are expected to remain at $1.11 per share in the coming year.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Doximity is 14.94, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.40.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Doximity is 14.94, which means that it is trading at a more expensive P/E ratio than the Services sector average P/E ratio of about 10.41.

  • Price to Earnings Growth Ratio

    Doximity has a PEG Ratio of 1.88. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Doximity has a P/B Ratio of 3.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    13.40% of the float of Doximity has been sold short.
  • Short Interest Ratio / Days to Cover

    Doximity has a short interest ratio ("days to cover") of 5.43.
  • Change versus previous month

    Short interest in Doximity has recently increased by 12.87%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Doximity does not currently pay a dividend.

  • Dividend Growth

    Doximity does not have a long track record of dividend growth.

  • News Sentiment

    Doximity has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.84 average news sentiment score of Services companies.
  • News Coverage This Week

    MarketBeat has tracked 35 news articles for Doximity this week, compared to 6 articles on an average week.
  • Search Interest

    29 people have searched for DOCS on MarketBeat in the last 30 days. This is an increase of 93% compared to the previous 30 days.
  • MarketBeat Follows

    Only 5 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $456,061.00 in company stock.

  • Percentage Held by Insiders

    31.30% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Doximity's insider trading history.
Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DOCS Stock News Headlines

5 Things to Know Before the Stock Market Opens
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide. On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.tc pixel
Doximity Q4 2026 Earnings Call Transcript
Doximity (DOCS) Q4 2026 Earnings Transcript
See More Headlines

DOCS Stock Analysis - Frequently Asked Questions

Doximity's stock was trading at $44.26 at the beginning of the year. Since then, DOCS stock has decreased by 60.0% and is now trading at $17.72.

Doximity, Inc. (NYSE:DOCS) posted its quarterly earnings data on Thursday, February, 5th. The company reported $0.46 earnings per share for the quarter, beating analysts' consensus estimates of $0.45 by $0.01. The firm's revenue was up 9.8% compared to the same quarter last year.
Read the conference call transcript
.

Doximity's board initiated a stock buyback program on Thursday, February 5th 2026, which authorizes the company to repurchase $500,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 8% of its shares through open market purchases. Shares repurchase programs are often an indication that the company's board believes its shares are undervalued.

Doximity (DOCS) raised $501 million in an IPO on Thursday, June 24th 2021. The company issued 23,300,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities served as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers.

Top institutional investors of Doximity include SG Americas Securities LLC (0.76%), Dimensional Fund Advisors LP (0.74%), Bank of New York Mellon Corp (0.56%) and Swedbank AB (0.55%). Insiders that own company stock include Anna Bryson, Craig Overpeck, Siddharth Sitaram, Regina M Benjamin, Kira Scherer Wampler, Watkin Phoebe L Yang and Timothy S Cabral.
View institutional ownership trends
.

Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Doximity investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), CrowdStrike (CRWD), PayPal (PYPL) and Invesco QQQ (QQQ).

Company Calendar

Last Earnings
2/05/2026
Today
5/14/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Services
Industry
Services – Computer Programming And Data Processing
Sub-Industry
Computer Software
Current Symbol
NYSE:DOCS
Previous Symbol
NASDAQ:DOCS
CIK
1516513
Web
N/A
Fax
N/A
Employees
890
Year Founded
2010

Price Target and Rating

High Price Target
$65.00
Low Price Target
$18.00
Potential Upside/Downside
+78.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.52
Research Coverage
23 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.20
Trailing P/E Ratio
14.81
Forward P/E Ratio
16.02
P/E Growth
1.88
Net Income
$223.18 million
Net Margins
37.54%
Pretax Margin
43.32%
Return on Equity
23.84%
Return on Assets
20.42%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.63
Quick Ratio
6.63

Sales & Book Value

Annual Sales
$570.40 million
Price / Sales
5.76
Cash Flow
$0.85 per share
Price / Cash Flow
21.00
Book Value
$5.73 per share
Price / Book
3.10

Miscellaneous

Outstanding Shares
184,710,000
Free Float
126,895,000
Market Cap
$3.29 billion
Optionable
N/A
Beta
1.36

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:DOCS) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners